Videos & Presentations

Our Purpose:
To be a driving force in the early detection of lung cancer.

April 1, 2022

Presentation: Full Year Results for the year ended 31 December 2021

Paul Pagano and David Anderson give a presentation on LungLife's Annual Results for the year ended 31 December 2021, via the Investor Meet Company platform.  
• View Media
January 27, 2022

Edison Open House interview with CEO, Paul Pagano

LungLife AI: Edison Open House Healthcare 2022
• View Media
September 9, 2021

Half Year Results to 30 June, 2021

Paul Pagano and David Anderson talk with Justin Waite of VOX Markets. Paul Pagano and David Anderson's presentation to the investor community on the results to the period.
• View Media
July 9, 2021

Introduction to LungLife AI, Inc post Admission

Paul Pagano talks with Paul Hill of VOX Markets following the Company's IPO on 8 July, 2021.
• View Media

Media inquiries

© 2020 LungLIfe AI, Inc.
All rights reserved. LiquidBiopsy is a trademark of LungLife AI, Inc.
magnifiercrossmenuchevron-down